Rose merc Limited has successfully allotted 10,000 equity shares to employees under its Employee Stock Option Plan II, 2023. The Compensation Committee approved this allotment on January 28th, 2026, marking another milestone in the company's employee incentive program.

Share Allotment Details

The allotment comprises 10,000 equity shares with a face value of Rs. 10 each, fully paid-up. These shares were issued upon exercise of stock options under the "RML Employee Stock Option Plan II, 2023" (RML ESOP II - 2023).

Impact on Share Capital

Following this allotment, Rose Merc Limited's capital structure has been enhanced. The newly allotted shares rank pari-passu with existing equity shares in all respects.

ESOP Scheme Overview

The RML Employee Stock Option Plan II, 2023 demonstrates the company's commitment to employee participation in its growth. The scheme encompasses significant provisions for employee benefit and retention.

Key Scheme Features:

• Total Options Granted: 21,95,000 stock options to 5 eligible employees
• Vesting Period: 1 year from grant date
• Exercise Window: 4 years from vesting date
• Convertibility: Each option convertible into one fully paid-up equity share
• Administration: Managed by the Compensation Committee

Regulatory Compliance

The allotment was conducted in full compliance with regulatory requirements. The company filed necessary disclosures under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The scheme filing with BSE was completed on August 11th, 2023, ensuring all procedural requirements were met before the option exercise. The newly issued shares carry no lock-in restrictions and will be available for trading immediately upon listing.

Rose merc Limited has announced the resignation of its Managing Director, Mr. Kirti Savla, effective January 21, 2026. The company informed BSE Limited about this key leadership change in compliance with regulatory requirements, marking a significant transition in the company's management structure.

Resignation Details and Regulatory Compliance

The resignation was formally communicated to BSE Limited under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Executive Director Vaishali Parkar Kumar signed the official intimation on behalf of Rose Merc Limited, ensuring full regulatory compliance.

Health Reasons Drive Leadership Change

Mr. Savla cited personal health reasons as the primary factor behind his decision to resign from the Managing Director position. In his resignation letter, he emphasized that these health concerns require his full attention, necessitating his departure from the leadership role. The company has confirmed that there are no other material reasons for his resignation, providing transparency to stakeholders.

Positive Transition Message

Despite stepping down, Mr. Savla expressed strong confidence in the company's management and future prospects. In his resignation letter, he stated his happiness with the way management has been functioning and praised the professionalism, dedication, and teamwork witnessed during his tenure. He assured the Board of his full support for a smooth transition process and offered assistance during the handover period.

Regulatory Documentation

The company has submitted comprehensive documentation to BSE Limited, including the formal resignation letter and annexures as required under SEBI regulations. The submission includes details mandated by SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, ensuring complete regulatory compliance during this leadership transition.

The resignation represents a significant change in Rose Merc Limited's leadership structure, with the company now focusing on ensuring continuity in operations and management effectiveness during this transition period.